Company Overview

Sai Capital Limited published its 31st Annual Report for FY2025-26, containing standalone and consolidated financial statements along with notice of the Annual General Meeting scheduled for August 25, 2026. The document represents a comprehensive regulatory filing pursuant to SEBI LODR requirements.

Financial Performance Highlights

Standalone Performance: The company reported a net loss of ₹68.23 lakhs with zero revenue from operations and total expenses of ₹68.23 lakhs. Basic & diluted EPS stood at (₹2.37).

Consolidated Performance: Despite the standalone loss, the company achieved a consolidated net profit of ₹1,255.69 lakhs, driven significantly by other income of ₹2,386.93 lakhs. Total comprehensive income reached ₹1,256.40 lakhs with basic & diluted EPS of ₹43.61. Revenue from operations was ₹66.64 lakhs.

Annual General Meeting Details

The 31st AGM will be held on August 25, 2026, through video conferencing. Key agenda items include:

  • Adoption of audited standalone and consolidated financial statements
  • Reappointment of Mr. Ankur Rawat as director retiring by rotation
  • Special resolution for reappointment of Dr. Niraj Kumar Singh as Chairman & Managing Director for a further 5-year term from June 2027 to June 2032

Remote e-voting will be available from August 22-24, 2026, through NSDL.

Subsidiary Performance

The company has three material subsidiaries:

1. Health Care Energy Foods Private Limited (98.10% holding): Generated net profit of ₹1,678.73 lakhs

2. Butterfly Ayurveda Private Limited (98.10% holding): Reported net loss of (₹354.21) lakhs with revenue of ₹66.64 lakhs

3. Unisphere Industries Private Limited (step-down subsidiary): Net loss of (₹0.59) lakhs

Financial Instrument Disclosures

The company disclosed contractual cash flows for non-derivative financial liabilities totaling ₹1,892.57 lakhs, with borrowings maturing across various periods. The debt-equity ratio remained stable at 0.01 for both March 2025 and March 2026, with total debt increasing from ₹431.55 lakhs to ₹499.08 lakhs.

Fair value measurements showed loans at amortized cost comprising ₹31,675.80 lakhs as of March 2026. Carrying amounts of trade receivables, cash equivalents, and other short-term instruments are considered equivalent to their fair values.

Related Party Transactions

Extensive related party transactions were disclosed totaling ₹774.92 lakhs, including:

  • Remuneration paid to key management personnel including Mr. Ankur Rawat (₹19.05 lakhs) and Mr. Karan Mehra (₹9.36 lakhs)
  • Net loans and advances to related parties including Ms. Akshi Khandelwal (₹31.67 lakhs)
  • Transactions with subsidiary companies including Butterfly Ayurveda Bakery Private Limited and Health Care Energy Foods Private Limited
  • Interest received on loans and purchase/sale of goods between related entities

Corporate Governance and Compliance

The board composition includes 4 directors (1 executive, 1 non-executive non-independent, 2 non-executive independent). Five board meetings were held during the year with full attendance from most directors. The company maintains all required policies including vigil mechanism and whistle blower policy, with no complaints received during the year.

Auditors' reports were unqualified but highlighted material uncertainty regarding going concern status due to accumulated losses of ₹765.02 lakhs and net current liabilities of ₹5.36 lakhs. Management believes the company will continue as a going concern based on business strategies and operating plans.

No dividend was recommended for FY2025-26 due to absence of distributable profit on standalone basis.